Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000892569-07-000181
Filing Date
2007-03-01
Accepted
2007-03-01 16:32:47
Documents
10
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a27771e10vk.htm 10-K 1629540
2 EXHIBIT 10.34 a27771exv10w34.txt EX-10.34 118114
3 EXHIBIT 10.35 a27771exv10w35.txt EX-10.35 26575
4 EXHIBIT 21 a27771exv21.htm EX-21 8996
5 EXHIBIT 23 a27771exv23.htm EX-23 1430
6 EXHIBIT 31.1 a27771exv31w1.htm EX-31.1 8936
7 EXHIBIT 31.2 a27771exv31w2.htm EX-31.2 8941
8 EXHIBIT 32 a27771exv32.htm EX-32 5669
9 GRAPHIC a27771a2777101.gif GRAPHIC 9852
10 GRAPHIC a27771a2777102.gif GRAPHIC 9870
  Complete submission text file 0000892569-07-000181.txt   1837259
Mailing Address 3300 HYLAND AVE COSTA MESA CA 92626
Business Address 3300 HYLAND AVE COSTA MESA CA 92626 7145450100
VALEANT PHARMACEUTICALS INTERNATIONAL (Filer) CIK: 0000930184 (see all company filings)

EIN.: 330628076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11397 | Film No.: 07663859
SIC: 2834 Pharmaceutical Preparations